Fund Holdings — Privium Fund Management B.V.

Total Portfolio Value
$556.26M
Total Bought
$85.15M
Total Sold
$82.22M
Net Transaction
+$2.93M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
TESLA INC(TSLA)242,000244,000+2,00074,670108,51219.51%+33,841
UNIQURE NV(QURE)447,486386,000-61,4866,26022,5314.05%+16,270
SHOPIFY INC(SHOP)430,000415,000-15,00048,97161,67311.09%+12,702
ADVANCED MICRO DEVICES INC(AMD)060,000+60,00009,7071.75%+9,707
LEMONADE INC(LMND)0145,000+145,00007,7621.40%+7,762
ARROWHEAD PHARMACEUTICALS IN(ARWR)612,214473,951-138,2639,85116,3472.94%+6,496
IREN LIMITED
ORDINARY SHARES
0130,000+130,00006,1011.10%+6,101
IONIS PHARMACEUTICALS INC(IONS)267,594248,894-18,70010,68816,2832.93%+5,595
AST SPACEMOBILE INC(ASTS)0110,000+110,00005,3990.97%+5,399
BIOGEN INC(BIIB)20,50051,925+31,4252,6667,2741.31%+4,607
NVIDIA CORPORATION(NVDA)81,00081,000012,53015,1132.72%+2,583
ABIVAX SA(ABVX)030,412+30,41202,5820.46%+2,582
UROGEN PHARMA LTD(URGN)107,622196,622+89,0001,4013,9230.71%+2,521
COINBASE GLOBAL INC(COIN)70,00079,000+9,00024,18626,6624.79%+2,476
BEAM THERAPEUTICS INC(BEAM)061,000+61,00001,4800.27%+1,480
HIMS & HERS HEALTH INC(HIMS)22,00040,000+18,0001,0972,2690.41%+1,172
ARCUTIS BIOTHERAPEUTICS INC(ARQT)344,472305,972-38,5004,7365,7681.04%+1,031
AVIDITY BIOSCIENCES INC46,00053,000+7,0001,3092,3090.42%+1,000
AXSOME THERAPEUTICS INC(AXSM)52,73252,73205,4306,4041.15%+974
4D MOLECULAR THERAPEUTICS IN197,458197,45808191,7160.31%+896
KRYSTAL BIOTECH INC(KRYS)9,32012,170+2,8501,2962,1480.39%+853
ALX ONCOLOGY HLDGS INC(ALXO)509,059509,05902219320.17%+711
BIONTECH SE(BNTX)10,98719,000+8,0131,1811,8740.34%+693
SCHLUMBERGER LTD(SLB)019,697+19,69706770.12%+677
PROQR THRAPEUTICS N V
SHS EURO
4,997,5624,998,287+72510,04510,6461.91%+601
MERCK & CO INC(MRK)59,09364,393+5,3004,8345,4050.97%+570
ROIVANT SCIENCES LTD(ROIV)126,923126,92301,3891,9200.35%+532
LEXEO THERAPEUTICS INC(LXEO)178,356192,356+14,0007531,2770.23%+525
SEABRIDGE GOLD INC(SA)44,07448,474+4,4006481,1710.21%+522
CRISPR THERAPEUTICS AG(CRSP)44,70040,000-4,7002,1682,5920.47%+424
WAVE LIFE SCIENCES LTD(WVE)135,550170,000+34,4508841,2440.22%+361
TRANSOCEAN LTD(RIG)0102,000+102,00003180.06%+318
FATE THERAPEUTICS INC(FATE)111,090333,219+222,1291274200.08%+293
ROCKET PHARMACEUTICALS INC(RCKT)432,760432,76001,1211,4110.25%+290
MEIRAGTX HLDGS PLC(MGTX)163,000163,00001,0561,3410.24%+285
SANDRIDGE ENERGY INC(SD)37,02250,392+13,3704015680.10%+167
VIZSLA SILVER CORP(VZLA)250,790204,654-46,1367328840.16%+152
VOYAGER THERAPEUTICS INC(VYGR)25,24145,000+19,759792100.04%+131
TAYSHA GENE THERAPIES INC(TSHA)134,900134,90003164410.08%+125
AMBEV SA(ABEV)795,786897,134+101,3481,9262,0010.36%+75
SIBANYE STILLWATER LTD(SBSW)34,04026,232-7,8082482950.05%+47
TIDEWATER INC NEW(TDW)5,3505,483+1332552920.05%+37
PFIZER INC(PFE)37,02937,750+7219279620.17%+35
NOV INC(NOV)63,87663,87608258460.15%+21
NOBLE CORP PLC(NE)14,28714,28703924040.07%+12
RECURSION PHARMACEUTICALS IN(RXRX)119,000119,00006105810.10%-30
AMAZON COM INC(AMZN)149,000149,000032,77232,7165.88%-56
SPROTT FDS TR
URANI MINER ETF
16,27811,448-4,8307616920.12%-69
PAN AMERN SILVER CORP(PAAS)29,74718,531-11,2168457180.13%-127
ZAI LAB LTD(ZLAB)132,189132,18904,6494,4800.81%-169
AUTOLUS THERAPEUTICS PLC(AUTL)294,142308,837+14,6956745030.09%-170
VALARIS LTD(VAL)13,8038,315-5,4886064060.07%-200
DYNE THERAPEUTICS INC(DYN)27,5660-27,5662390—-239
ULTRAGENYX PHARMACEUTICAL IN(RARE)253,304289,804+36,5009,1858,7171.57%-467
VERTEX PHARMACEUTICALS INC(VRTX)8,3008,30003,7533,2510.58%-502
EMX RTY CORP216,9680-216,9685450—-545
SAREPTA THERAPEUTICS INC(SRPT)39,4000-39,4006980—-698
ACADIA PHARMACEUTICALS INC148,40070,400-78,0003,1701,5020.27%-1,667
CARVANA CO(CVNA)5,0000-5,0001,6850—-1,685
MODERNA INC(MRNA)103,43347,000-56,4332,9671,2140.22%-1,753
SEA LTD(SE)210,000160,000-50,00032,50228,5975.14%-3,905
PALANTIR TECHNOLOGIES INC(PLTR)350,000200,000-150,00046,58436,4846.56%-10,100
SPOTIFY TECHNOLOGY S A(SPOT)114,00095,000-19,00084,82266,31011.92%-18,512
Page 1 of 1
Privium Fund Management B.V. — 13F Holdings — Q3 2025 | TickerTrail